Ritusri Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 12-12-2024
- Paid Up Capital ₹ 1.00 M
as on 12-12-2024
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.20 M
as on 12-12-2024
- Revenue 763.36%
(FY 2021)
- Profit 242.57%
(FY 2021)
- Ebitda 529.84%
(FY 2021)
- Net Worth 248.75%
(FY 2021)
- Total Assets 16.49%
(FY 2021)
About Ritusri Life Sciences
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.20 M.
Suharlith Kondepogu and Jayaprakash Sapidi serve as directors at the Company.
- CIN/LLPIN
U15100TG2019PTC133810
- Company No.
133810
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ritusri Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suharlith Kondepogu  | Director | 07-Apr-2022 | Current |
| Jayaprakash Sapidi | Director | 07-Apr-2022 | Current |
Financial Performance of Ritusri Life Sciences.
Ritusri Life Sciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 763.36% increase. The company also saw a substantial improvement in profitability, with a 242.57% increase in profit. The company's net worth Soared by an impressive increase of 248.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ritusri Life Sciences?
In 2021, Ritusri Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 23 Jun 2020 | ₹0.20 M | Open |
Canara Bank Creation Date: 24 Dec 2019 | ₹1.00 M | Open |
How Many Employees Work at Ritusri Life Sciences?
Unlock and access historical data on people associated with Ritusri Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ritusri Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ritusri Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
